362 related articles for article (PubMed ID: 15537371)
1. Olanzapine: a review of its use in the management of bipolar I disorder.
McCormack PL; Wiseman LR
Drugs; 2004; 64(23):2709-26. PubMed ID: 15537371
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on olanzapine in bipolar I disorder.
McCormack PL; Wiseman LR
CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine in long-term treatment for bipolar disorder.
Cipriani A; Rendell JM; Geddes J
Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
[TBL] [Abstract][Full Text] [Related]
7. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol alone or in combination for acute mania.
Cipriani A; Rendell JM; Geddes JR
Cochrane Database Syst Rev; 2006 Jul; (3):CD004362. PubMed ID: 16856043
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
10. Typical and atypical antipsychotics in bipolar depression.
Gao K; Gajwani P; Elhaj O; Calabrese JR
J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
[TBL] [Abstract][Full Text] [Related]
11. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Perlis RH
Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine: a review of its use in the treatment of bipolar I disorder.
Bhana N; Perry CM
CNS Drugs; 2001; 15(11):871-904. PubMed ID: 11700151
[TBL] [Abstract][Full Text] [Related]
13. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
[TBL] [Abstract][Full Text] [Related]
14. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
Dando TM; Keating GM
Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
[TBL] [Abstract][Full Text] [Related]
17. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bipolar mania with atypical antipsychotics.
Chengappa KN; Suppes T; Berk M
Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
